Both TMEM16F-dependent and TMEM16F-independent pathways contribute to phosphatidylserine exposure in platelet apoptosis and platelet activation

Blood

Volumn 121, Issue 10, 2013, Pages 1850-1857

  Van Kruchten, Roger ^a   Mattheij, Nadine J A ^a   Saunders, Christine ^b   Feijge, Marion A H ^a   Swieringa, Frauke ^a   Wolfs, Jef L N ^a   Collins, Peter W ^c   Heemskerk, Johan W M ^a   Bevers, Edouard M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Welsh Blood Service   (United Kingdom)

^c CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE; CALCIUM; CASPASE; COLLAGEN; CONVULXIN; CYCLOPHILIN D; PHOSPHATIDYLSERINE; PROTEIN; THROMBIN; TMEM16F PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CELL STIMULATION; CHELATION; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MEMBRANE DEPOLARIZATION; MITOCHONDRION; PRIORITY JOURNAL; SCOTT SYNDROME; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE ACTIVATION;

EID: 84876516813     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-09-454314     Document Type: Article

References (29)

1. Bevers EM, Williamson PL. Phospholipid scramblase: an update. FEBS Lett. 2010;584(13): 2724-2730.
2. Fadok VA, Voelker DR, Campbell PA, et al. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol. 1992;148(7): 2207-2216.
3. Heemskerk JW, Bevers EM, Lindhout T. Platelet activation and blood coagulation. Thromb Haemost. 2002;88(2):186-193. (Pubitemid 34873696)
4. Lentz BR. Exposure of platelet membrane phosphatidylserine regulates blood coagulation. Prog Lipid Res. 2003;42(5):423-438. (Pubitemid 36694106)
5. Heemskerk JW, Kuijpers MJ, Munnix IC, et al. Platelet collagen receptors and coagulation. A characteristic platelet response as possible target for antithrombotic treatment. Trends Cardiovasc Med. 2005;15(3):86-92. (Pubitemid 41021731)
6. Rosing J, van Rijn JL, Bevers EM, et al. The role of activated human platelets in prothrombin and factor X activation. Blood. 1985;65(2):319-332. (Pubitemid 15163567)
7. Arachiche A, Kerbiriou-Nabias D, Garcin I, et al. Rapid procoagulant phosphatidylserine exposure relies on high cytosolic calcium rather than on mitochondrial depolarization. Arterioscler Thromb Vasc Biol. 2009;29(11):1883-1889.
8. Dale GL, Friese P. Bax activators potentiate coated-platelet formation. J Thromb Haemost. 2006;4(12):2664-2669. (Pubitemid 44741563)
9. Jobe SM, Wilson KM, Leo L, et al. Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis. Blood. 2008;111(3):1257-1265. (Pubitemid 351213408)
10. Zwaal RF, Comfurius P, Bevers EM. Scott syndrome, a bleeding disorder caused by defective scrambling of membrane phospholipids. Biochim Biophys Acta. 2004;1636(2-3):119-128. (Pubitemid 38780788)
11. Munnix IC, Harmsma M, Giddings JC, et al. Storemediated calcium entry in the regulation of phosphatidylserine exposure in blood cells from Scott patients. Thromb Haemost. 2003;89(4): 687-695. (Pubitemid 36456966)
12. Suzuki J, Umeda M, Sims PJ, et al. Calciumdependent phospholipid scrambling by TMEM16F. Nature. 2010;468(7325):834-838.
13. Castoldi E, Collins PW, Williamson PL, et al. Compound heterozygosity for 2 novel TMEM16F mutations in a patient with Scott syndrome. Blood. 2011;117(16):4399-4400.
14. Schoenwaelder SM, Yuan Y, Josefsson EC, et al. Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function. Blood. 2009;114(3):663-666.
15. Zhang H, Nimmer PM, Tahir SK, et al. Bcl-2 family proteins are essential for platelet survival. Cell Death Differ. 2007;14(5):943-951. (Pubitemid 46655455)
16. Kile BT. The role of the intrinsic apoptosis pathway in platelet life and death. J Thromb Haemost. 2009;(7 Suppl 12):14-217.
17. Kodama T, Takehara T, Hikita H, et al. BH3-only activator proteins Bid and Bim are dispensable for Bak/Bax-dependent thrombocyte apoptosis induced by Bcl-xL deficiency: molecular requisites for the mitochondrial pathway to apoptosis in platelets. J Biol Chem. 2011;286(16): 13905-13913.
18. Mason KD, Carpinelli MR, Fletcher JI, et al. Programmed anuclear cell death delimits platelet life span. Cell. 2007;128(6):1173-1186. (Pubitemid 46427871)
19. Schoenwaelder SM, Jarman KE, Gardiner EE, et al. Bcl-xL-inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets. Blood. 2011; 118(6):1663-1674.
20. VoglerM, HamaliHA, Sun XM, et al. BCL2/BCL-X(L) inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation. Blood. 2011;117(26):7145-7154.
21. Siljander P, Farndale RW, Feijge MA, et al. Platelet adhesion enhances the glycoprotein VIdependent procoagulant response: Involvement of p38 MAP kinase and calpain. Arterioscler Thromb Vasc Biol. 2001;21(4):618-627. (Pubitemid 32323397)
22. van der Meijden PE, Feijge MA, Giesen PL, et al. Platelet P2Y12 receptors enhance signalling towards procoagulant activity and thrombin generation. A study with healthy subjects and patients at thrombotic risk. Thromb Haemost. 2005;93(6):1128-1136. (Pubitemid 40823519)
23. Jackson SP, Schoenwaelder SM. Procoagulant platelets: are they necrotic? Blood. 2010;116(12): 2011-2018.
24. Zong WX, Thompson CB. Necrotic death as a cell fate. Genes Dev. 2006;20(1):1-15. (Pubitemid 43042662)
25. Williamson P, Christie A, Kohlin T, et al. Phospholipid scramblase activation pathways in lymphocytes. Biochemistry. 2001;40(27): 8065-8072. (Pubitemid 32641203)
26. Brooks MB, Catalfamo JL, Friese P, et al. Scott syndrome dogs have impaired coated-platelet formation and calcein-release but normal mitochondrial depolarization. J Thromb Haemost. 2007;5(9):1972-1974. (Pubitemid 47288957)
27. Rosing J, Bevers EM, Comfurius P, et al. Impaired factor X and prothrombin activation associated with decreased phospholipid exposure in platelets from a patient with a bleeding disorder. Blood. 1985;65(6):1557-1561. (Pubitemid 15057969)
28. Dasgupta SK, Argaiz ER, Mercado JE, et al. Platelet senescence and phosphatidylserine exposure. Transfusion. 2010;50(10):2167-2175.
29. Nieswandt B, Watson SP. Platelet-collagen interaction: is GPVI the central receptor? Blood. 2003;102(2):449-461. (Pubitemid 36841960)